Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Zhejiang Provincial Center for Disease Control and Prevention clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Zhejiang Provincial Center for Disease Control and Prevention as lead sponsor. Synced 15 Oct 2026
3Current trials
0Recruiting now
2Drugs in these trials
1Trial register
At a glance

Zhejiang Provincial Center for Disease Control and Prevention is the lead sponsor of 3 current clinical trials in our China register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Phase 4. The drugs named most often in its trials are 9-valent HPV vaccine and Bivalent HPV vaccine. The most-studied condition is HPV Infection.

ClinicalTrials.gov trials by status

  • Not yet open267%
  • Active, closed133%

Trials by phase

  • Phase 4267%
  • Observational133%
01

Clinical trials sponsored by Zhejiang Provincial Center for Disease Control and Prevention

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Childhood Infection and Immunity Longitudinal Cohort
NCT07815925 · ClinicalTrials.gov ↗ · Immunity, Respiratory Infection, Asthma
Observational Not yet open 2026-09 China
Study on Changes in Gut Microbiota, Inflammatory Factors, and Bowel Habits Following Oral Administration of Recombinant B-subunit/Whole Cell Cholera Vaccine in a Community Population
NCT07873346 · ClinicalTrials.gov ↗ · Bowel Habits, Gut Microbiomes, Inflamatory Markers
Phase 4 Not yet open 2026-10 China
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
NCT07281677 · ClinicalTrials.gov ↗ · HPV Infection
Phase 4 Active, closed 2025-12 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Zhejiang Provincial Center for Disease Control and Prevention trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Zhejiang Provincial Center for Disease Control and Prevention trials

7 conditions
HPV Infection1Immunity1Respiratory Infection1Asthma1Bowel Habits1Gut Microbiomes1Inflamatory Markers1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China30

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in HPV Infection

SponsorTrials
Frantz Viral Therapeutics3
Weill Medical College of Cornell University2
Sinocelltech1
Lo.Li.Pharma1

Sponsors with the most current trials registered for this condition.

06

Questions about Zhejiang Provincial Center for Disease Control and Prevention trials

How many clinical trials does Zhejiang Provincial Center for Disease Control and Prevention sponsor?

Zhejiang Provincial Center for Disease Control and Prevention is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 15 October 2026. Completed and withdrawn studies are not counted.

Are Zhejiang Provincial Center for Disease Control and Prevention trials recruiting?

Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Which drugs is Zhejiang Provincial Center for Disease Control and Prevention testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are 9-valent HPV vaccine (1) and Bivalent HPV vaccine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.